Promising new results from psychedelic clinic...

Send us Fan MailIn 2023, the U.S. Surgeon General issued a powerful advisory declaring loneliness and social disconnection a public health crisis. Sometimes called the “loneliness epidemic,” it reflects how—even in a hyperconnected, social media world—many of us feel more isolate ...  Show more

Send us Fan MailIn today’s episode of the Psychedelic Therapy Frontiers podcast we discuss a paper recently published in JAMA (Journal of the American Medical Association) entitled, “Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder: A Randomized Clinical Tr ...  Show more

<span style= "font-size: 10.0pt; mso-bidi-font-family: Arial; mso-bidi-font-style: italic;"> What do the clinical trials of psilocybin and other psychedelics show in terms of efficacy and safety? How much of the benefit with psychedelic treatment is attributa ...

It's time to make psychiatry more psychedelic, says psychiatrist Benjamin Lewis. Sharing results from his clinical trial on psychedelic-assisted therapy, he highlights how group therapy paired with the safe use of psilocybin, a compound found in magic mushrooms, has the potential ...  Show more

In this Huberman Lab Essentials episode, my guest is Dr. Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics. We explore the science and therapeutic po ...  Show more

In this episode Michelle interviews Dr. Steve Thayer, a clinical psychologist at Cedar Psychiatry, about his work using psychotherapy in conjunction with ketamine, a legal and safe psychedelic substance. Michelle shares her personal experience with Dr. Thayer when she participate ...  Show more